NO973034L - Apoptose-modulerende preparat omfattende en faktor som påvirker det intracellulære nivå av methional eller malondialdehyd - Google Patents

Apoptose-modulerende preparat omfattende en faktor som påvirker det intracellulære nivå av methional eller malondialdehyd

Info

Publication number
NO973034L
NO973034L NO973034A NO973034A NO973034L NO 973034 L NO973034 L NO 973034L NO 973034 A NO973034 A NO 973034A NO 973034 A NO973034 A NO 973034A NO 973034 L NO973034 L NO 973034L
Authority
NO
Norway
Prior art keywords
methional
malondialdehyde
factor affecting
intracellular level
apoptosis
Prior art date
Application number
NO973034A
Other languages
English (en)
Other versions
NO973034D0 (no
Inventor
Georges Anthony Quash
Alain Doutheau
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird Galderma filed Critical Cird Galderma
Publication of NO973034D0 publication Critical patent/NO973034D0/no
Publication of NO973034L publication Critical patent/NO973034L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forbindelse som er valgt fra methional, malondialdehyd og enhver faktor som påvirker det intracellulære nivå av methional eller av malondialdehyd, og som er egnet som et legemiddel. Legemiddelet er særlig bestemt for modulering av programmert celledød (apoptose). Oppfinnelsen vedrører også et apoptose-modulert farmasøytisk eller kosmetisk preparat som er kjennetegnet ved at det omfatter en aktiv bestanddel som utgjøres av en forbindelse valgt fra methional, malondialdehyd eller enhver faktor som påvirker det intracellulære nivå av methional eller av malondialdehyd, i en kon±)inasjon med en farmasøytisk eller kosmetisk tålbar bærer. Oppfinnelsen tilveiebringer også en metode for å forhindre og/eller bekjempe lysindusert aldring av huden eller aldringen av huden som er forbundet med tid.
NO973034A 1994-12-29 1997-06-27 Apoptose-modulerende preparat omfattende en faktor som påvirker det intracellulære nivå av methional eller malondialdehyd NO973034L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415884A FR2728790B1 (fr) 1994-12-29 1994-12-29 Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
PCT/FR1995/001715 WO1996020701A1 (fr) 1994-12-29 1995-12-22 Composition modulant l'apoptose comprenant un facteur influençant le taux intracellulaire de methional ou de malondialdehyde

Publications (2)

Publication Number Publication Date
NO973034D0 NO973034D0 (no) 1997-06-27
NO973034L true NO973034L (no) 1997-08-29

Family

ID=9470424

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973034A NO973034L (no) 1994-12-29 1997-06-27 Apoptose-modulerende preparat omfattende en faktor som påvirker det intracellulære nivå av methional eller malondialdehyd

Country Status (24)

Country Link
US (1) US5744499A (no)
EP (1) EP0723778B1 (no)
JP (1) JP2000515845A (no)
KR (1) KR100310499B1 (no)
AR (1) AR001783A1 (no)
AT (1) ATE191339T1 (no)
AU (1) AU704064B2 (no)
BR (1) BR9510509A (no)
CA (1) CA2166243C (no)
DE (1) DE69516107T2 (no)
DK (1) DK0723778T3 (no)
ES (1) ES2147272T3 (no)
FI (1) FI972780A7 (no)
FR (1) FR2728790B1 (no)
GR (1) GR3033732T3 (no)
HU (1) HUT77490A (no)
IL (1) IL116586A0 (no)
NO (1) NO973034L (no)
NZ (1) NZ298831A (no)
PL (1) PL182597B1 (no)
PT (1) PT723778E (no)
RU (1) RU2160103C2 (no)
WO (1) WO1996020701A1 (no)
ZA (1) ZA9511015B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517622D0 (en) * 1995-08-29 1995-11-01 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
FR2761606B1 (fr) * 1997-04-08 1999-05-14 Cird Galderma Utilisation de derives aminothiolesters dans le domaine pharmaceutique
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
WO1999042606A1 (en) 1998-02-23 1999-08-26 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US7951989B2 (en) * 1998-02-23 2011-05-31 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US6656449B1 (en) * 1998-02-23 2003-12-02 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
BR9908713A (pt) * 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
FR2777001B1 (fr) * 1998-04-01 2000-06-09 Cird Galderma Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses
TW544310B (en) * 1998-04-02 2003-08-01 Ajinomoto Kk Amino acid derivatives and anti-inflammatory agents
ES2286908T3 (es) 1998-12-01 2007-12-01 Phylonix Pharmaceuticals Inc. Metodos para introducir celulas heterologas en peces.
CN1424900A (zh) * 1999-11-24 2003-06-18 通达商业集团国际公司 局部皮肤用组合物
JP2003515558A (ja) * 1999-12-06 2003-05-07 ロード アイランド ホスピタル， ア ライフスパン パートナー 腫瘍を治療するためのメチロール含有化合物の使用
US20070003536A1 (en) * 2000-11-21 2007-01-04 Zimmerman Amy C Topical skin compositions, their preparation, and their use
US20080124409A1 (en) * 2000-11-21 2008-05-29 Access Business Group International Llc Topical Skin Compositions, Their Preparation, and Their Use
WO2002094271A1 (en) * 2001-05-15 2002-11-28 Faulk Pharmaceuticals, Inc. Targeted delivery of bioaffecting compounds for the treatment of cancer
US20030129262A1 (en) * 2001-08-30 2003-07-10 Epner Daniel E. Methionine restriction for cancer therapy
EP1432815A4 (en) * 2001-09-14 2006-02-22 Univ Duke QUINONE REDUCTASE 2 AND ALDEHYDE DESHYDROGENASE USED AS THERAPEUTIC TARGETS
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
US20050152995A1 (en) * 2003-06-27 2005-07-14 Chen Dong F. Methods and compositions for promoting axon regeneration and cell replacement therapy
WO2009144253A1 (en) * 2008-05-29 2009-12-03 Karolinska Institutet Innovations Ab Compounds comprising a 3-pyridinol or 5-pyrimidinol ring having an organoseleno or organotelluro substituent for use as antioxidants
SE537517C2 (sv) 2012-12-14 2015-05-26 Stora Enso Oyj Våtlagt arkmaterial innefattande mikrofibrillerad cellulosasamt förfarande för tillverkning därav
WO2017005910A1 (en) * 2015-07-09 2017-01-12 Metabolic Explorer Methionine hydroxy analog (mha) pathways for production by fermentation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716898A (en) * 1980-07-03 1982-01-28 Kureha Chem Ind Co Ltd Prostaglandin controller containing aminobenzoic derivative
SU1537247A1 (ru) * 1980-08-21 1990-01-23 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Антигеморрагическое средство "Эмоксипин" дл рассасывани внутриглазных кровоизли ний
SU1375259A1 (ru) * 1983-02-11 1988-02-23 Институт Химической Физики Ан Ссср Фотопротектор дл лечени ожогов сетчатой оболочки глаза
HU201240B (en) * 1987-03-18 1990-10-28 Caola Kozmetikai Cosmetical composition for regeneration of skin
FR2673530B1 (fr) * 1991-03-06 1995-05-19 Monique Moreau Extraits de feuilles de murier, antiradicalaires et antimalondialdehyde.

Also Published As

Publication number Publication date
NZ298831A (en) 2001-04-27
ZA9511015B (en) 1996-08-12
FR2728790B1 (fr) 1997-01-24
RU2160103C2 (ru) 2000-12-10
MX9704491A (es) 1997-10-31
FI972780A0 (fi) 1997-06-27
AU704064B2 (en) 1999-04-15
HUT77490A (hu) 1998-05-28
CA2166243A1 (fr) 1996-06-30
FI972780L (fi) 1997-06-27
US5744499A (en) 1998-04-28
PL320963A1 (en) 1997-11-24
KR970706807A (ko) 1997-12-01
AU4451296A (en) 1996-07-24
CA2166243C (fr) 2003-07-01
IL116586A0 (en) 1996-03-31
KR100310499B1 (ko) 2001-12-12
WO1996020701A1 (fr) 1996-07-11
FR2728790A1 (fr) 1996-07-05
DE69516107T2 (de) 2000-11-16
FI972780A7 (fi) 1997-06-27
PT723778E (pt) 2000-09-29
DK0723778T3 (da) 2000-07-10
EP0723778A1 (fr) 1996-07-31
JP2000515845A (ja) 2000-11-28
EP0723778B1 (fr) 2000-04-05
AR001783A1 (es) 1997-12-10
NO973034D0 (no) 1997-06-27
PL182597B1 (pl) 2002-02-28
DE69516107D1 (de) 2000-05-11
GR3033732T3 (en) 2000-10-31
ES2147272T3 (es) 2000-09-01
ATE191339T1 (de) 2000-04-15
BR9510509A (pt) 1998-07-07

Similar Documents

Publication Publication Date Title
BR0009830A (pt) Composições para cuidados com a pele contendo uma combinação de substâncias ativas para cuidados com a pele
ES2055860T3 (es) Derivados 2-aminopirimidinona.
SE8503680L (sv) Indolderivat
WO2005011627A3 (en) Regulation of mammalian keratinous tissue using n-acyl amino acid compositons
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
EA200500088A1 (ru) Трициклические модуляторы ядерного рецептора стероидного гормона
DK0738152T3 (da) Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer
EP0265514A4 (en) Drugs for the inhibition of ridicule.
SK282579B6 (sk) Parenterálne farmaceutické prípravky a spôsob ich prípravy
DK92781A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK0600544T3 (da) Anvendelse af lycopen til at reducere aktivitet af celler, især af cancerceller, og farmaceutiske præparater
AU5910996A (en) Pyrrole derivatives and medicinal composition
NO941977L (no) Indolderivater, fremgangsmåte for fremstilling av disse, og medisinsk anvendelse derav
EP0754457A4 (en) ACTIVE AGAINST ADDICT
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
AU546492B2 (en) Stabilization of pharmaceutical compositions containing acid addition salts of thieno-pyridine derivatives
NO993841L (no) Blandinger og anordninger for redusering av virkningene av inflammasjon
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
RU95110110A (ru) Производные бензофурана, способ их получения, фармкомпозиция и способ лечения
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
DK0486385T3 (da) Imidazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0632717T3 (da) Middel til anvendelse som et anti-irritationsmiddel
DK0712838T3 (da) Acylphenylglycinderivat og forebyggende middel og lægemiddel til sygdomme, der er forårsaget af en forøget kollagenaseaktiv

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application